UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
ASSETS
Cash and cash equivalents	$ 8,071	$ 6,174
Restricted cash and equivalents	270,981	119,257
Finance receivables measured at fair value	3,132,310	2,722,662
Finance receivables	8,274	27,553
Less: Allowance for finance credit losses	(486)	(2,869)
Finance receivables, net	7,788	24,684
Furniture and equipment, net	1,078	1,372
Deferred tax assets, net	1,565	3,736
Other assets	40,899	25,861
Total assets	3,462,692	2,903,746
Liabilities
Accounts payable and accrued expenses	72,626	62,544
Warehouse lines of credit	105,783	234,025
Residual interest financing	99,127	49,875
Securitization trust debt	2,875,777	2,265,446
Subordinated renewable notes	24,288	17,188
Total liabilities	3,177,601	2,629,078
COMMITMENTS AND CONTINGENCIES
Shareholders' Equity
Common stock, no par value; authorized 75,000,000 shares; 21,405,198 and 21,174,856 shares issued and outstanding at September 30, 2024 and December 31, 2023, respectively	25,043	28,678
Retained earnings	261,915	247,857
Accumulated other comprehensive loss	(1,867)	(1,867)
Total shareholders' equity	285,091	274,668
Total liabilities and shareholders' equity	3,462,692	2,903,746
Preferred Stock [Member]
Shareholders' Equity
Preferred stock, value	0	0
Series A Preferred Stock [Member]
Shareholders' Equity
Preferred stock, value	0	0
Series B Preferred Stock [Member]
Shareholders' Equity
Preferred stock, value	$ 0	$ 0